[1] |
蒲诗函, 庞曼丽, 徐丽梅. 糖尿病患者并发皮肤瘙痒症的影响因素分析 [J]. 解放军医药杂志, 2021, 33(07): 78-81.
|
[2] |
Duff M, Demidova O, Blackburn S, et al. Cutaneous manifestations of diabetes mellitus [J]. Clin Diabetes, 2015, 33(1): 40-48.
|
[3] |
Stefaniak AA, Chlebicka I, Szepietowski JC. Itch in diabetes: a common underestimated problem [J]. Postepy Dermatol Alergol, 2021, 38(2): 177-183.
|
[4] |
杨敏, 刘琬, 高小曼, 等. 老年人2型糖尿病合并皮肤疾病的临床分析 [J]. 中华老年医学杂志, 2017, 36(9): 955-958.
|
[5] |
王艳. 赛肤润对糖尿病皮肤瘙痒症作用效果的非随机对照临床试验 [J]. 中国实用护理杂志, 2016, 32(19): 1470-1474.
|
[6] |
MatsudaKM, SharmaD, SchonfeldAR, et al. Gabapentin and pregabalin for the treatment of chronic pruritus [J]. J Am Acad Dermatol, 2016, 75(3): 619-625, e6.
|
[7] |
张学军, 陆洪光, 高兴华. 皮肤性病学(第8版) [M]. 北京: 人民卫生出版社, 2013: 135-135.
|
[8] |
朱小华, 张臻, 吴金峰, 等. 普瑞巴林胶囊联合地氯雷他定片治疗老年皮肤瘙痒症的临床观察 [J]. 老年医学与保健, 2022, 28(3): 675-677, 693.
|
[9] |
梁钊雄. 普瑞巴林胶囊辅助治疗尿毒症皮肤瘙痒患者的效果分析 [J]. 海峡药学, 2020, 32(3): 153-154.
|
[10] |
Mathieson S, Lin CC, Underwood M, et al. Pregabalin and gabapentin for pain [J]. BMJ, 2020, 28(369): m1315.
|
[11] |
Calandre EP, Rico-Villademoros F, Slim M. Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use [J]. Expert Rev Neurother, 2016, 16(11): 1263-1277.
|
[12] |
Matsuda KM, Sharma D, Schonfeld AR, et al. Gabapentin and pregabalin for the treatment of chronic pruritus [J]. J Am Acad Dermatol, 2016, 75(3): 619-625.e6.
|
[13] |
Ko MJ, Peng YS, Wu HY. Uremic pruritus: pathophysiology, clinical presentation, and treatments [J]. Kidney Res Clin Pract, 2023, 42(1): 39-52.
|
[14] |
Kaul I, Amin A, Rosenberg M, et al. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review [J]. Burns, 2018, 44(2): 414-422.
|
[15] |
张文, 蔡涛. 新型抗癫痫药物治疗慢性瘙痒研究进展 [J]. 中国药业, 2020, 29(10): 153-160.
|
[16] |
鞠延娇, 尤艳明, 谢志强. 加巴喷丁及普瑞巴林治疗慢性瘙痒的研究进展 [J]. 中国中西医结合皮肤性病学杂志, 2017, 16(4): 373-376.
|
[17] |
Mittal A, Agarwal C, Balai M, et al. Gabapentin and pregabalin in dermatology [J]. Indian J Dermatol Venereol Leprol, 2018, 84(5): 634-640.
|
[18] |
鲁娟, 周小栋, 谭伟. 普瑞巴林辅助抗组胺类药物治疗尿毒症行维持性血液透析患者继发皮肤瘙痒的临床观察 [J]. 中国药房, 2016, 27(5): 668-670.
|
[19] |
Shamspour N, Aflatoonian M, Khalili M,et al. Comparison of Pregabalin and Ketotifen in treatment of uremic pruritus in hemodialysis patients [J]. Dermatol Ther, 2022, 35(7): e15579.
|
[20] |
吴方来, 汪四虎, 黄大祥, 等. 2型糖尿病并发皮肤瘙痒症的临床特征及相关危险因素分析 [J]. 中国糖尿病杂志, 2019, 27(11): 825-828.
|
[21] |
Yang QP, Chen YY, Li Z, et al.Major risk factors analysis of pruritus complicated by type 2 diabetes mellitus and the effect of comprehensive nursing intervention [J]. Front Surg, 2022, 9: 842884.
|
[22] |
Chen YY, Yang QP, Peng SP, et al. Risk factors and psychological condition of pruritus in type 2 diabetes mellitus: a retrospective, propensity score-matched study [J]. Eur Rev Med Pharmacol Sci, 2022, 26(15): 5353-5361.
|
[23] |
Stefaniak AA,Krajewski PK, Bednarska-Chabowska D,et al. Itch in Adult Population with Type 2 Diabetes Mellitus:Clinical Profile, Pathogenesis and Disease-Related Burden in aCross-Sectional Study [J]. Biology (Basel), 2021, 10(12): 1332-1348.
|
[24] |
杨平安, 刘赫. 糖尿病伴瘙痒症的识别、特征及处理 [J]. 实用糖尿病杂志, 2018, 14(1): 10-11.
|
[25] |
李霞. 分析二甲双胍、口服氯雷他定片与滋阴除湿汤加减治疗糖尿病性老年皮肤瘙痒症阴虚湿恋证的效果 [J]. 糖尿病新世界, 2022, 25(14): 13-16.
|
[26] |
Weisshaar E, Szepietowski JC, Dalgard FJ, et al.European S2k guideline on chronic pruritus [J]. Acta Derm Venereol, 2019, 99(5): 469-506.
|